1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA AATK-AS1 CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA ABCC1 CTRPv2 pan-cancer AAC -0.12 0.0003
mRNA ABCC3 CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA ABCC8 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA ABCD4 CTRPv2 pan-cancer AAC 0.12 0.0003
mRNA ABHD17B CTRPv2 pan-cancer AAC 0.2 5e-09
mRNA ABL2 CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA ABLIM2 CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA ABLIM3 CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA ABRACL CTRPv2 pan-cancer AAC 0.16 5e-06
Download CSV